Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran+28 more
core +1 more source
Effect of vitamin D status on a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) and interleukin 6 in patients with acute myeloid leukaemia. [PDF]
Abdelhady DA+3 more
europepmc +1 more source
Open or closed? Understanding the molecular mechanisms and clinical implications of ADAMTS13's conformation. [PDF]
Bonnez Q, Vanhoorelbeke K.
europepmc +1 more source
Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation. [PDF]
DeYoung V+6 more
europepmc +1 more source
Successful Treatment of refractory Thrombotic Thrombocytopenic Purpura With The Monoclonal Antibody Rituximab :A case Report [PDF]
Much of thrombotic thrombocytopenic purpura (TTP) is attributed to the presence of an autoantibody to ADAMTS-13, the metalloprotease that degrades ultralarge von Willebrand protein multimers.
فتحی, افشین+1 more
core
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study. [PDF]
Mavrikou I+16 more
europepmc +1 more source
The essential role of calcium in ADAMTS13 function
Imperial Users ...
Gardner, Michelle Daniela+1 more
core
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome. [PDF]
Weisinger J+17 more
europepmc +1 more source
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study. [PDF]
Silingardi M+14 more
europepmc +1 more source
Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis. [PDF]
Liu Y+9 more
europepmc +1 more source